» Articles » PMID: 27009752

Calcium and 1,25-dihydroxyvitamin D3 Modulate Genes of Immune and Inflammatory Pathways in the Human Colon: a Human Crossover Trial

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2016 Mar 25
PMID 27009752
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A high dietary calcium intake with adequate vitamin D status has been linked to lower colorectal cancer risk, but the mechanisms of these effects are poorly understood.

Objective: The objective of this study was to elucidate the effects of a Western-style diet (WD) and supplemental calcium and/or 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] on the colorectal mucosa.

Design: We conducted 2 crossover trials to define molecular pathways in the human colorectum altered by 1) a 4-wk WD supplemented with and without 2 g calcium carbonate/d and 2) a 4-wk WD supplemented with 1,25(OH)2D3 (0.5 μg/d) with or without 2 g calcium carbonate/d. The primary study endpoint was genome-wide gene expression in biopsy specimens of the rectosigmoid colonic mucosa. Serum and urinary calcium concentrations were also measured.

Results: Changes in urinary calcium accurately reflected calcium consumption. The WD induced modest upregulation of genes involved in inflammatory pathways, including interferon signaling, and calcium supplementation reversed these toward baseline. In contrast, supplementation of the WD with 1,25(OH)2D3 induced striking upregulation of genes involved in inflammation, immune response, extracellular matrix, and cell adhesion. Calcium supplementation largely abrogated these changes.

Conclusions: Supplementing 1,25(OH)2D3 to a WD markedly upregulated genes in immune response and inflammation pathways, which were largely reversed by calcium supplementation. This study provides clinical trial evidence of global gene expression changes occurring in the human colorectum in response to calcium and 1,25(OH)2D3 intervention. One action of 1,25(OH)2D3 is to upregulate adaptive immunity. Calcium appears to modulate this effect, pointing to its biological interaction in the mucosa. This trial was registered at clinicaltrials.gov as NCT00298545 Trial protocol is available at http://clinicalstudies.rucares.org (protocol numbers PHO475 and PHO554).

Citing Articles

Serum magnesium, not calcium, is inversely associated with abnormal HbA1c concentrations in adults with coronary artery disease.

Dong H, Lu N, Wang J, Hu P Asia Pac J Clin Nutr. 2025; 34(1):104-111.

PMID: 39828263 PMC: 11742607. DOI: 10.6133/apjcn.202502_34(1).0010.


Vitamin D and potential effects on cancers: a review.

Sobhi P, Bahrami M, Mahdizadeh F, Fazaeli A, Babaei G, Rezagholizadeh L Mol Biol Rep. 2024; 51(1):190.

PMID: 38270702 DOI: 10.1007/s11033-023-09111-y.


A feasibility study of perioperative vitamin D supplementation in patients undergoing colorectal cancer resection.

Vaughan-Shaw P, Buijs L, Blackmur J, Ewing A, Becher H, Theodoratou E Front Nutr. 2023; 10():1106431.

PMID: 37063332 PMC: 10103841. DOI: 10.3389/fnut.2023.1106431.


Vitamin D and Calcium as Key Potential Factors Related to Colorectal Cancer Prevention and Treatment: A Systematic Review.

Cruz-Pierard S, Nestares T, Amaro-Gahete F Nutrients. 2022; 14(22).

PMID: 36432621 PMC: 9692441. DOI: 10.3390/nu14224934.


Linkages of Various Calcium Sources on Immune Performance, Diarrhea Rate, Intestinal Barrier, and Post-gut Microbial Structure and Function in Piglets.

Wang K, Yang A, Peng X, Lv F, Wang Y, Cui Y Front Nutr. 2022; 9:921773.

PMID: 35782941 PMC: 9248811. DOI: 10.3389/fnut.2022.921773.


References
1.
Protiva P, Cross H, Hopkins M, Kallay E, Bises G, Dreyhaupt E . Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity. Cancer Prev Res (Phila). 2009; 2(1):43-51. DOI: 10.1158/1940-6207.CAPR-08-0103. View

2.
Newmark H, Yang K, Kurihara N, Fan K, Augenlicht L, Lipkin M . Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis. 2008; 30(1):88-92. PMC: 2722141. DOI: 10.1093/carcin/bgn229. View

3.
Jenab M, Bueno-de-Mesquita H, Ferrari P, van Duijnhoven F, Norat T, Pischon T . Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ. 2010; 340:b5500. PMC: 2809840. DOI: 10.1136/bmj.b5500. View

4.
Sun J . Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 2010; 26(6):591-5. PMC: 2955835. DOI: 10.1097/MOG.0b013e32833d4b9f. View

5.
Ahearn T, McCullough M, Flanders W, Long Q, Sidelnikov E, Fedirko V . A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Res. 2010; 71(2):413-23. PMC: 3064476. DOI: 10.1158/0008-5472.CAN-10-1560. View